Activation of 2'-5' oligoadenylate synthetase by single-stranded and double-stranded RNA aptamers.
about
Activation of 2' 5'-oligoadenylate synthetase by stem loops at the 5'-end of the West Nile virus genomeInhibition of 2'-5' oligoadenylate synthetase by divalent metal ionsMonoallelic and biallelic mutations in MAB21L2 cause a spectrum of major eye malformationsp59OASL, a 2'-5' oligoadenylate synthetase like protein: a novel human gene related to the 2'-5' oligoadenylate synthetase familyThe Roles of RNase-L in Antimicrobial Immunity and the Cytoskeleton-Associated Innate ResponseActivation and evasion of the antiviral 2'-5' oligoadenylate synthetase/ribonuclease L pathway by hepatitis C virus mRNA.The Flvr-encoded murine oligoadenylate synthetase 1b (Oas1b) suppresses 2-5A synthesis in intact cellsExpression and characterization of recombinant 2',5'-oligoadenylate synthetase from the marine sponge Geodia cydonium.RNase-L-dependent destabilization of interferon-induced mRNAs. A role for the 2-5A system in attenuation of the interferon response.A novel RNA molecular signature for activation of 2'-5' oligoadenylate synthetase-1Structural mechanism of sensing long dsRNA via a noncatalytic domain in human oligoadenylate synthetase 3Local neutral networks help maintain inaccurately replicating ribozymesSelection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2',5'-oligoadenylate synthetase from prostate cancer cellsNucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase LPathologic effects of RNase-L dysregulation in immunity and proliferative control.Contrasted patterns of variation and evolutionary convergence at the antiviral OAS1 gene in old world primates.Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C.Intracellular immune dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome: state of the art and therapeutic implications.Multi-level regulation of cellular recognition of viral dsRNA.The 2'-5'-oligoadenylate synthetase 3 enzyme potently synthesizes the 2'-5'-oligoadenylates required for RNase L activation.Interferon-alpha synergistically enhances induction of interleukin-6 by double stranded RNA in HeLa cells.Induction and activation of antiviral enzyme 2',5'-oligoadenylate synthetase by in vitro transcribed insulin mRNA and other cellular RNAs.RNase L mediates transient control of the interferon response through modulation of the double-stranded RNA-dependent protein kinase PKR.Murine pancreatic beta TC3 cells show greater 2', 5'-oligoadenylate synthetase (2'5'AS) antiviral enzyme activity and apoptosis following IFN-alpha or poly(I:C) treatment than pancreatic alpha TC3 cells.Induction of (2'-5')oligoadenylate synthetase in the marine sponges Suberites domuncula and Geodia cydonium by the bacterial endotoxin lipopolysaccharide.Genetic variants of interferon-stimulated genes and IL-28B as host prognostic factors of response to combination treatment for chronic hepatitis C.Multiple signaling cascades are differentially involved in gene induction by double stranded RNA in interferon-alpha-primed cells.A human cellular noncoding RNA activates the antiviral protein 2'-5'-oligoadenylate synthetase 1
P2860
Q21089709-C5E73BF7-1E6B-4432-89B3-415E6EAB0399Q24291839-BA3BB35C-776C-46EB-AA68-6612C2D38BB6Q24298949-43AD5355-D981-43B4-A5F4-00B7D0579006Q24548239-9F91FD97-B495-4CB8-8339-E6BE75060867Q26772138-7BAFE221-B6B9-4537-8745-D98DFB7362CFQ27472961-2099652D-3B2B-4EA8-97CA-8A3C5A4B159CQ28513485-4F91FEBA-0156-4F0A-9797-DD85E5BA1805Q33287329-99903DAD-CEEF-49B3-B28B-34391A01C9C4Q33893743-589F20B1-2A7C-4760-AB87-2AC1AFB516D2Q34883331-C770CD63-2788-482E-82E5-B354106A7385Q35279639-CDFC899D-6D6C-41C9-95A3-50FD861824BBQ35316425-036B6C68-FA09-44EE-94FA-CCDA72ACA8B4Q35545869-294C0FC7-5011-41AE-BE6F-E7FCDD3E59F7Q35620847-D90C6FB2-1A0D-4AC3-99E0-C0B75FAB48A7Q36310770-B416ADBA-EBBB-4747-A3AF-F72F4FC766A1Q36732659-D75B19BE-73D7-47C6-B2F4-BDEFD3B082FDQ37028594-79D725E4-24A7-427E-98A5-474B9C03EA24Q37082766-0AC8C3BF-C31C-4F79-B343-01E9E393C25AQ38041927-D0C643AC-7B6D-45BB-AD14-B1F937F8183CQ38303787-C07AA3F2-8B82-4A30-9A2A-1B8D4BA0B01EQ38312785-3566F2F2-0ADB-4259-B8B0-AD2C399AED49Q39356003-8ED617F7-2644-4949-90DE-A18970206C94Q40671154-0CC5924E-A82A-4F81-8C03-B0AA9B75914CQ42077490-D6A0F88A-B00B-4ACE-AF99-129531AD02CFQ48315615-6A87BF1D-F075-4697-A168-9CEF8542BD8BQ50554860-169D17F2-C03C-450C-B224-12AB6CC43918Q52138897-C8315716-CE6C-43A6-849A-45CDDDAC5186Q58732375-DDAC1F95-D7A5-42B4-823F-D90E5B457EFA
P2860
Activation of 2'-5' oligoadenylate synthetase by single-stranded and double-stranded RNA aptamers.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Activation of 2'-5' oligoadeny ...... double-stranded RNA aptamers.
@en
type
label
Activation of 2'-5' oligoadeny ...... double-stranded RNA aptamers.
@en
prefLabel
Activation of 2'-5' oligoadeny ...... double-stranded RNA aptamers.
@en
P2093
P2860
P50
P356
P1476
Activation of 2'-5' oligoadeny ...... double-stranded RNA aptamers.
@en
P2093
C Jacobsen
J Justesen
M J Clemens
P Jorgensen
P2860
P304
P356
10.1074/JBC.273.6.3236
P407
P577
1998-02-01T00:00:00Z